Skip to main content

Table 5 Hematologic toxicity associated with GFIP/BDC by type and grade

From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

Toxicity

None

Grade 1

Grade 2

Grade 3

Grade 4

Anemia

0

1

1

1

0

Neutropenia

0

0

7

1

1

Thrombocytopenia

0

0

4

2

0